157 related articles for article (PubMed ID: 31866013)
1. Interaction with the heparin-derived binding inhibitors destabilizes galectin-3 protein structure.
Sindrewicz P; Yates EA; Turnbull JE; Lian LY; Yu LG
Biochem Biophys Res Commun; 2020 Mar; 523(2):336-341. PubMed ID: 31866013
[TBL] [Abstract][Full Text] [Related]
2. Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.
Duckworth CA; Guimond SE; Sindrewicz P; Hughes AJ; French NS; Lian LY; Yates EA; Pritchard DM; Rhodes JM; Turnbull JE; Yu LG
Oncotarget; 2015 Sep; 6(27):23671-87. PubMed ID: 26160844
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic tryptophan fluorescence spectroscopy reliably determines galectin-ligand interactions.
Sindrewicz P; Li X; Yates EA; Turnbull JE; Lian LY; Yu LG
Sci Rep; 2019 Aug; 9(1):11851. PubMed ID: 31413267
[TBL] [Abstract][Full Text] [Related]
4. Lactulose as a novel template for anticancer drug development targeting galectins.
Kishor C; Ross RL; Blanchard H
Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
[TBL] [Abstract][Full Text] [Related]
5. Binding of Gold(III) Porphyrin by the Pro-metastatic Regulatory Protein Human Galectin-3.
Bogoeva V; Rangelov M; Todorova N; Lambert A; Bridot C; Yordanova A; Roos G; Grandjean C; Bouckaert J
Molecules; 2019 Dec; 24(24):. PubMed ID: 31842510
[TBL] [Abstract][Full Text] [Related]
6. Development of an AlphaScreen assay for discovery of inhibitors of low-affinity glycan-lectin interactions.
Yegorova S; Chavaroche AE; Rodriguez MC; Minond D; Cudic M
Anal Biochem; 2013 Aug; 439(2):123-31. PubMed ID: 23685052
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamics of bovine spleen galectin-1 binding to disaccharides: correlation with structure and its effect on oligomerization at the denaturation temperature.
Schwarz FP; Ahmed H; Bianchet MA; Amzel LM; Vasta GR
Biochemistry; 1998 Apr; 37(17):5867-77. PubMed ID: 9558320
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
[TBL] [Abstract][Full Text] [Related]
9. Biophysical and structural characterization of mono/di-arylated lactosamine derivatives interaction with human galectin-3.
Atmanene C; Ronin C; Téletchéa S; Gautier FM; Djedaïni-Pilard F; Ciesielski F; Vivat V; Grandjean C
Biochem Biophys Res Commun; 2017 Jul; 489(3):281-286. PubMed ID: 28554839
[TBL] [Abstract][Full Text] [Related]
10. Nuclear transport of galectin-3 and its therapeutic implications.
Funasaka T; Raz A; Nangia-Makker P
Semin Cancer Biol; 2014 Aug; 27():30-8. PubMed ID: 24657939
[TBL] [Abstract][Full Text] [Related]
11. The water network in galectin-3 ligand binding site guides inhibitor design.
Su J; Zhang T; Wang P; Liu F; Tai G; Zhou Y
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):192-8. PubMed ID: 25662390
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Yu LG; Andrews N; Zhao Q; McKean D; Williams JF; Connor LJ; Gerasimenko OV; Hilkens J; Hirabayashi J; Kasai K; Rhodes JM
J Biol Chem; 2007 Jan; 282(1):773-81. PubMed ID: 17090543
[TBL] [Abstract][Full Text] [Related]
13. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.
Peterson K; Kumar R; Stenström O; Verma P; Verma PR; Håkansson M; Kahl-Knutsson B; Zetterberg F; Leffler H; Akke M; Logan DT; Nilsson UJ
J Med Chem; 2018 Feb; 61(3):1164-1175. PubMed ID: 29284090
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.
Gao X; Zhi Y; Sun L; Peng X; Zhang T; Xue H; Tai G; Zhou Y
J Biol Chem; 2013 Nov; 288(47):33953-33965. PubMed ID: 24100038
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Design of a Monosaccharide Ligand Targeting Galectin-8.
Bohari MH; Yu X; Kishor C; Patel B; Go RM; Eslampanah Seyedi HA; Vinik Y; Grice ID; Zick Y; Blanchard H
ChemMedChem; 2018 Aug; 13(16):1664-1672. PubMed ID: 29926535
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3--a jack-of-all-trades in cancer.
Newlaczyl AU; Yu LG
Cancer Lett; 2011 Dec; 313(2):123-8. PubMed ID: 21974805
[TBL] [Abstract][Full Text] [Related]
17. HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway.
Yao Y; Zhou L; Liao W; Chen H; Du Z; Shao C; Wang P; Ding K
Carbohydr Polym; 2019 Jan; 204():111-123. PubMed ID: 30366522
[TBL] [Abstract][Full Text] [Related]
18. Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives.
Téllez-Sanz R; García-Fuentes L; Vargas-Berenguel A
Curr Med Chem; 2013; 20(24):2979-90. PubMed ID: 23834183
[TBL] [Abstract][Full Text] [Related]
19. Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3.
Diehl C; Engström O; Delaine T; Håkansson M; Genheden S; Modig K; Leffler H; Ryde U; Nilsson UJ; Akke M
J Am Chem Soc; 2010 Oct; 132(41):14577-89. PubMed ID: 20873837
[TBL] [Abstract][Full Text] [Related]
20. NMR and MD investigations of human galectin-1/oligosaccharide complexes.
Meynier C; Feracci M; Espeli M; Chaspoul F; Gallice P; Schiff C; Guerlesquin F; Roche P
Biophys J; 2009 Dec; 97(12):3168-77. PubMed ID: 20006954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
